Work

Tu1670 Inhibition of Corticotropin-Releasing Hormone Receptor 2 (CRHR2) Expression in Colorectal Cancer Correlates With Tumor Growth and EMT In Vitro and In Vivo, Poor Patient Survival and Increased Risk for Distant Metastases